EUVIMEDEUVIMED entdecken
Kommentar

Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?

Edward A Levine

JAMA Surgery · 2023

DOI: 10.1001/jamasurg.2023.0119 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Surgery, 2023. Verfasst von Edward A Levine. Beteiligte Einrichtung: Surgical Oncology Service, Wake Forest University, Winston-Salem, North Carolina. Hauptthemen laut MEDLINE: Pseudomyxoma Peritonei, Peritoneal Neoplasms, Hyperthermia, Induced. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomyxoma PeritoneiPeritoneal NeoplasmsHyperthermia, InducedHumansPrognosisHyperthermic Intraperitoneal ChemotherapyNomogramsCytoreduction Surgical ProceduresCombined Modality TherapyRetrospective Studies

Autor:innen und Institutionen

  • Surgical Oncology Service, Wake Forest University, Winston-Salem, North Carolina.

Zitieren

APA

Levine, E. A. (2023). Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?. JAMA Surgery. https://doi.org/10.1001/jamasurg.2023.0119

Vancouver

Levine EA. Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?. JAMA Surgery. 2023. doi:10.1001/jamasurg.2023.0119

BibTeX
@article{Levine2023,
  author = {Levine, Edward A},
  title = {Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?},
  journal = {JAMA Surgery},
  year = {2023},
  doi = {10.1001/jamasurg.2023.0119}
}
Kostenlos starten →